179 related articles for article (PubMed ID: 22562822)
1. The quantitative analysis by stem-loop real-time PCR revealed the microRNA-34a, microRNA-155 and microRNA-200c overexpression in human colorectal cancer.
Wang M; Zhang P; Li Y; Liu G; Zhou B; Zhan L; Zhou Z; Sun X
Med Oncol; 2012 Dec; 29(5):3113-8. PubMed ID: 22562822
[TBL] [Abstract][Full Text] [Related]
2. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.
Liu XG; Zhu WY; Huang YY; Ma LN; Zhou SQ; Wang YK; Zeng F; Zhou JH; Zhang YK
Med Oncol; 2012 Jun; 29(2):618-26. PubMed ID: 21516486
[TBL] [Abstract][Full Text] [Related]
3. High microRNA-28-5p expression in colorectal adenocarcinoma predicts short-term relapse of node-negative patients and poor overall survival of patients with non-metastatic disease.
Tsiakanikas P; Kontos CK; Kerimis D; Papadopoulos IN; Scorilas A
Clin Chem Lab Med; 2018 May; 56(6):990-1000. PubMed ID: 29688883
[TBL] [Abstract][Full Text] [Related]
4. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
[TBL] [Abstract][Full Text] [Related]
5. RT-qPCR for Fecal Mature MicroRNA Quantification and Validation.
Ahmed FE; Ahmed NC; Gouda MM; Vos PW; Bonnerup C
Methods Mol Biol; 2018; 1765():203-215. PubMed ID: 29589310
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of miR-22 expression in patients with colorectal cancer.
Zhang G; Xia S; Tian H; Liu Z; Zhou T
Med Oncol; 2012 Dec; 29(5):3108-12. PubMed ID: 22492279
[TBL] [Abstract][Full Text] [Related]
7. miR-34a overexpression predicts poor prognostic outcome in colorectal adenocarcinoma, independently of clinicopathological factors with established prognostic value.
Rapti SM; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
Clin Biochem; 2017 Nov; 50(16-17):918-924. PubMed ID: 28624481
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A
Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.
Kerimis D; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
Clin Biochem; 2017 Apr; 50(6):285-292. PubMed ID: 27939727
[TBL] [Abstract][Full Text] [Related]
10. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.
Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A
Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer.
Wang CJ; Zhou ZG; Wang L; Yang L; Zhou B; Gu J; Chen HY; Sun XF
Dis Markers; 2009; 26(1):27-34. PubMed ID: 19242066
[TBL] [Abstract][Full Text] [Related]
12. Expression of miR-200c and its clinicopathological significance in patients with colorectal cancer.
Roh MS; Lee HW; Jung SB; Kim K; Lee EH; Park MI; Lee JS; Kim MS
Pathol Res Pract; 2018 Mar; 214(3):350-355. PubMed ID: 29496312
[TBL] [Abstract][Full Text] [Related]
13. Correlation analysis of miR-200b, miR-200c, and miR-141 with liver metastases in colorectal cancer patients.
Zhu SH; He XC; Wang L
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2357-2363. PubMed ID: 28617555
[TBL] [Abstract][Full Text] [Related]
14. Circulating serum miR-200c and miR-34a-5p as diagnostic biomarkers for endometriosis.
Misir S; Hepokur C; Oksasoglu B; Yildiz C; Yanik A; Aliyazicioglu Y
J Gynecol Obstet Hum Reprod; 2021 Apr; 50(4):102092. PubMed ID: 33601073
[TBL] [Abstract][Full Text] [Related]
15. Differential Expression of miR-20a and miR-145 in Colorectal Tumors as Potential Location-specific miRNAs.
Eslamizadeh S; Zare AA; Talebi A; Tabaeian SP; Eshkiki ZS; Heydari-Zarnagh H; Akbari A
Microrna; 2021; 10(1):66-73. PubMed ID: 33349227
[TBL] [Abstract][Full Text] [Related]
16. Aberrant microRNA expression in tumor mycosis fungoides.
Papadavid E; Braoudaki M; Bourdakou M; Lykoudi A; Nikolaou V; Tounta G; Ekonomidi A; Athanasiadis E; Spyrou G; Antoniou C; Kitsiou-Tzeli S; Rigopoulos D; Kolialexi A
Tumour Biol; 2016 Nov; 37(11):14667-14675. PubMed ID: 27623940
[TBL] [Abstract][Full Text] [Related]
17. Dicer and miRNA in relation to clinicopathological variables in colorectal cancer patients.
Stratmann J; Wang CJ; Gnosa S; Wallin A; Hinselwood D; Sun XF; Zhang H
BMC Cancer; 2011 Aug; 11():345. PubMed ID: 21827717
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA expression profile in patients with stage II colorectal cancer: a Turkish referral center study.
Tanoglu A; Balta AZ; Berber U; Ozdemir Y; Emirzeoglu L; Sayilir A; Sucullu I
Asian Pac J Cancer Prev; 2015; 16(5):1851-5. PubMed ID: 25773836
[TBL] [Abstract][Full Text] [Related]
19. Serological under expression of microRNA-21, microRNA-34a and microRNA-126 in colorectal cancer.
Almeida AL; Bernardes MV; Feitosa MR; Peria FM; Tirapelli DP; Rocha JJ; Feres O
Acta Cir Bras; 2016; 31 Suppl 1():13-8. PubMed ID: 27142899
[TBL] [Abstract][Full Text] [Related]
20. Circulating miR-200c levels significantly predict response to chemotherapy and prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer.
Tanaka K; Miyata H; Yamasaki M; Sugimura K; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S607-15. PubMed ID: 23838916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
